Norman Olbrich

Statistics

Publications

Citations

215

H-Index

Active since

2013

Affiliations

Baylor College of Medicine(Current)

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Parkland Health & Hospital System

Frederick National Laboratory for Cancer Research

Norman Olbrich is an author at Baylor College of Medicine specializing in pharmacotherapy, futility monitoring, and placebo-controlled efficacy assessment.

Publications per year

2013–2024

Publications

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +3

Thyroid Hormone-Induced Hypertrophy in Mesenchymal Stem Cell Chondrogenesis Is Mediated by Bone Morphogenetic Protein-4

Alexandra Karl, Norman Olbrich, Christian Pfeifer et al. · Tissue Engineering Part A · 2013 · 40 citations · Full text

Engineering, Bioengineering, Cell Biology +15

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Eleftherios Mylonakis, Barnaby Edward Young, David M. Vock et al. · Annals of Internal Medicine · 2022 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Neil R. Aggarwal, Jacquie Nordwall, Dominique L. Braun et al. · Clinical Infectious Diseases · 2024 · 16 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

1–4 of 4